These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6649539)

  • 1. [Clinico-laboratory studies in oncology].
    Sokolova II; Bergut FA; Gracheva ZA; Zaslavskaia MG; Zel'vin BM
    Vopr Onkol; 1983; 29(11):23-7. PubMed ID: 6649539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunologic consequences of laparoscopy in oncology.
    Carter JJ; Whelan RL
    Surg Oncol Clin N Am; 2001 Jul; 10(3):655-77. PubMed ID: 11685934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term intravenous administration of activated autologous lymphocytes for cancer patients does not induce antinuclear antibody and rheumatoid factor.
    Yamaguchi T; Bamba K; Kitayama A; Kuroiwa Y; Yoshimatsu K; Shimakawa T; Ogawa K; Sekine T; Shimizu N; Yamamoto K
    Anticancer Res; 2004; 24(4):2423-9. PubMed ID: 15330194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
    Liu L; Wu G; Yao JX; Ding Q; Huang SA
    Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Critical study of immunological assessment in cancer patients (author's transl)].
    Bagarry-Liegey D; Meyer G
    Bull Cancer; 1981; 68(5):403-16. PubMed ID: 7332788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.
    Wu F; Wang ZB; Lu P; Xu ZL; Chen WZ; Zhu H; Jin CB
    Ultrasound Med Biol; 2004 Sep; 30(9):1217-22. PubMed ID: 15550325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J; Pajtasz-Piasecka E
    Postepy Hig Med Dosw; 2003; 57(5):501-18. PubMed ID: 14737967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell-mediated immunity in patients with oral cancer. II: Correlation of peripheral lymphocyte reactivity with the clinical course].
    Seyama A
    Hiroshima Daigaku Shigaku Zasshi; 1982; 14(2):167-74. PubMed ID: 6963293
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine therapy for cancer: fact or fiction?
    Odunsi K; Lele S; Savalgi R
    Surg Technol Int; 2004; 13():39-47. PubMed ID: 15744673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assay for monitoring response to therapy in cancer patients.
    Wilhide CC; Larcom LL
    Ann Clin Lab Sci; 1993; 23(3):207-15. PubMed ID: 8323255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Links between innate and cognate tumor immunity.
    Ghiringhelli F; Apetoh L; Housseau F; Kroemer G; Zitvogel L
    Curr Opin Immunol; 2007 Apr; 19(2):224-31. PubMed ID: 17303400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognosis of cancer and the PPD reaction.
    Sato T; Suzuki S; Furukawa F; Watanabe I; Endo S
    Fukushima J Med Sci; 1981 Apr; 27(3-4):109-16. PubMed ID: 7347717
    [No Abstract]   [Full Text] [Related]  

  • 15. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Meregalli S; Porro G; Rovelli F; Vigorè L; Tisi E; D'Amico G
    Anticancer Res; 2009 May; 29(5):1847-52. PubMed ID: 19443415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin A: stimulation of immunity in lung cancer patients].
    Pletsitnyĭ KD; Vasipa SB; Shilin'sh VG; Iudin MIa
    Vopr Pitan; 1982; (5):60-2. PubMed ID: 6983779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional characteristics of lymphocytes and prognosis of malignant neoplasms].
    Sokolova II; Repina FF
    Ter Arkh; 1981; 53(11):10-2. PubMed ID: 7339894
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of lymphocyte function after radiation therapy for cancer in relationship to prognosis.
    Stratton JA; Fast PE; Weintraub I
    J Clin Lab Immunol; 1982 Feb; 7(2):147-53. PubMed ID: 7069785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.